Hafrun Fridriksdottir's Net Worth
$1.63 Million
Who is Hafrun Fridriksdottir?
Hafrun Fridriksdottir has an estimated net worth of $1.63 Million. This is based on reported shares across multiple companies, which include TEVA PHARMACEUTICAL INDUSTRIES LTD, Actavis plc, and Actavis, Inc..
SEC CIK
Hafrun Fridriksdottir's CIK is 0001561458
Past Insider Trading and Trends
2013 was Hafrun Fridriksdottir's most active year for acquiring shares with 4 total transactions. Hafrun Fridriksdottir's most active month to acquire stocks was the month of August. 2013 was Hafrun Fridriksdottir's most active year for disposing of shares, totalling 3 transactions. Hafrun Fridriksdottir's most active month to dispose stocks was the month of August. 2014 saw Hafrun Fridriksdottir paying a total of $250,056.45 for 1,269 shares, this is the most they've acquired in one year. In 2022 Hafrun Fridriksdottir cashed out on 130,000 shares for a total of $1,068,067.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Snapshot price: $12.32
Executive VP, Global R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -98.94% | -130.00K |
$8.22 | -$1,068,067.00 | 1.39K |
May 17
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actavis plc No price found
SVP, GLOBAL R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.48% | 1.27K |
$197.05 | $250,056.45 | 6.91K |
May 9
| |||
Form 4
|
∞
| 5.64K |
—
|
—
| 5.64K |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actavis, Inc. No price found
Sr VP, Global Generics R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.73K |
$144.00 |
—
|
0
|
Sep 30 - Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
∞
| 1.73K |
—
|
—
| 1.73K |
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||